Greater Individual Variability in Functional Brain Activity during Working Memory Performance in young people with Autism and Executive Function Impairment.


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2020
Historique:
received: 08 08 2019
revised: 12 03 2020
accepted: 02 04 2020
pubmed: 11 5 2020
medline: 9 3 2021
entrez: 11 5 2020
Statut: ppublish

Résumé

Individuals with autism spectrum disorder (ASD) often present with executive functioning (EF) deficits, including spatial working memory (SWM) impairment, which impedes real-world functioning. The present study examined task-related brain activity, connectivity and individual variability in fMRI-measured neural response during an SWM task in older youth and young adults with autism and clinically significant EF impairment. Neuroimaging was analyzed in 29 individuals with ASD without intellectual disability who had clinically significant EF impairment on the Behavior Rating Inventory of Executive Function, and 20 typically developing controls (participant age range=16-34). An SWM N-Back task was performed during fMRI. SWM activity (2-Back vs. 0-Back) and task-related dorsolateral prefrontal cortex (DLPFC) connectivity was examined within and between groups. Variability of neural response during SWM was also examined. During SWM performance both groups activated the expected networks, and no group differences in network activation or task-related DLPFC-connectivity were found. However, greater individual variability in the pattern of SWM activity was found in the ASD versus the typically developing control group. While there were no group differences in SWM task-evoked activity or connectivity, fronto-parietal network engagement was found to be more variable/idiosyncratic in ASD. Our results suggest that the fronto-parietal network may be shifted or sub-optimally engaged during SWM performance in participants with ASD with clinically significant EF impairment, with implications for developing targeted interventions for this subgroup.

Sections du résumé

BACKGROUND
Individuals with autism spectrum disorder (ASD) often present with executive functioning (EF) deficits, including spatial working memory (SWM) impairment, which impedes real-world functioning. The present study examined task-related brain activity, connectivity and individual variability in fMRI-measured neural response during an SWM task in older youth and young adults with autism and clinically significant EF impairment.
METHODS
Neuroimaging was analyzed in 29 individuals with ASD without intellectual disability who had clinically significant EF impairment on the Behavior Rating Inventory of Executive Function, and 20 typically developing controls (participant age range=16-34). An SWM N-Back task was performed during fMRI. SWM activity (2-Back vs. 0-Back) and task-related dorsolateral prefrontal cortex (DLPFC) connectivity was examined within and between groups. Variability of neural response during SWM was also examined.
RESULTS
During SWM performance both groups activated the expected networks, and no group differences in network activation or task-related DLPFC-connectivity were found. However, greater individual variability in the pattern of SWM activity was found in the ASD versus the typically developing control group.
CONCLUSIONS
While there were no group differences in SWM task-evoked activity or connectivity, fronto-parietal network engagement was found to be more variable/idiosyncratic in ASD. Our results suggest that the fronto-parietal network may be shifted or sub-optimally engaged during SWM performance in participants with ASD with clinically significant EF impairment, with implications for developing targeted interventions for this subgroup.

Identifiants

pubmed: 32388347
pii: S2213-1582(20)30097-8
doi: 10.1016/j.nicl.2020.102260
pmc: PMC7218076
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102260

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH113700
Pays : United States
Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Autism. 2009 May;13(3):245-64
pubmed: 19369387
Child Neuropsychol. 2002 Dec;8(4):241-8
pubmed: 12759821
Neuroimage. 2019 Apr 15;190:182-190
pubmed: 29355768
Psychiatry Res Neuroimaging. 2018 Dec 30;282:134-142
pubmed: 29945740
Science. 2014 Aug 29;345(6200):1054-7
pubmed: 25170153
Nature. 2016 Aug 11;536(7615):171-178
pubmed: 27437579
Neuroimage. 2020 Jan 15;205:116289
pubmed: 31629827
Am J Psychiatry. 2003 Apr;160(4):709-19
pubmed: 12668360
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Sep;2(6):537-545
pubmed: 29348041
PLoS One. 2016 Mar 30;11(3):e0152472
pubmed: 27027775
Front Neuroinform. 2011 Aug 22;5:13
pubmed: 21897815
J Int Neuropsychol Soc. 2010 May;16(3):495-505
pubmed: 20188014
Am J Psychiatry. 2010 Jul;167(7):748-51
pubmed: 20595427
Neuroimage Clin. 2019;21:101678
pubmed: 30708240
J Autism Dev Disord. 2015 May;45(5):1176-90
pubmed: 25326820
Dev Cogn Neurosci. 2016 Apr;18:34-48
pubmed: 26749076
PLoS One. 2013 Sep 05;8(9):e73789
pubmed: 24040072
Sci Transl Med. 2019 Feb 27;11(481):
pubmed: 30814340
PLoS Comput Biol. 2017 Feb 23;13(2):e1005350
pubmed: 28231282
Sci Rep. 2017 Jul 17;7(1):5533
pubmed: 28717229
Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 May;1(3):245-252
pubmed: 28083565
Neuropsychol Rev. 2008 Dec;18(4):320-38
pubmed: 18956239
Sci Rep. 2016 Nov 09;6:36566
pubmed: 27827406
Neuroimage. 2013 Feb 15;67:273-82
pubmed: 23142279
Cereb Cortex. 2000 Nov;10(11):1078-92
pubmed: 11053229
Neuroimage. 2014 May 15;92:381-97
pubmed: 24530839
Lancet Psychiatry. 2019 Oct;6(10):819-829
pubmed: 31447415
Dev Cogn Neurosci. 2019 Apr;36:100630
pubmed: 30878549
Annu Rev Psychol. 2013;64:135-68
pubmed: 23020641
J Autism Dev Disord. 1989 Jun;19(2):213-25
pubmed: 2745389
IEEE Trans Med Imaging. 2001 Jan;20(1):45-57
pubmed: 11293691
J Pediatr Psychol. 1985 Jun;10(2):215-25
pubmed: 4020603
J Psychiatry Neurosci. 2010 Nov;35(6):378-89
pubmed: 20731962
Neuroimage Clin. 2017 May 27;15:513-524
pubmed: 28652966
Child Neuropsychol. 2002 Dec;8(4):249-57
pubmed: 12759822
Nat Methods. 2019 Jan;16(1):111-116
pubmed: 30532080
J Neurodev Disord. 2018 Jun 1;10(1):19
pubmed: 29859034
Neuroimage. 2005 Feb 1;24(3):810-21
pubmed: 15652316
Neuroimage. 2012 Jul 16;61(4):1277-86
pubmed: 22484411
J Neural Transm (Vienna). 2010 Jan;117(1):105-22
pubmed: 19859782
J Psychiatr Res. 2017 Aug;91:64-73
pubmed: 28325680
Neuropsychol Rev. 2014 Sep;24(3):355-70
pubmed: 25143069
J Autism Dev Disord. 2017 Jul;47(7):2153-2162
pubmed: 28455721
Brain Stimul. 2009 Jan;2(1):14-21
pubmed: 20633399
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
Autism. 2014 Jan;18(1):31-44
pubmed: 24019124
Neuroimage. 2017 Apr 15;150:213-229
pubmed: 28213118
Biol Psychiatry. 2018 Aug 15;84(4):278-286
pubmed: 29703592
Psychol Assess. 2010 Mar;22(1):121-30
pubmed: 20230158
J Neurosci. 1994 Mar;14(3 Pt 2):1450-62
pubmed: 8126548
Comput Biomed Res. 1996 Jun;29(3):162-73
pubmed: 8812068
Brain. 2009 Apr;132(Pt 4):869-78
pubmed: 19174370
Neuroimage. 2014 Jan 1;84:320-41
pubmed: 23994314
Am J Intellect Dev Disabil. 2019 May;124(3):191-205
pubmed: 31026201
Neurology. 2003 Nov 11;61(9):1232-7
pubmed: 14610126
Neurology. 2002 Sep 24;59(6):834-40
pubmed: 12297562
Neurosci Biobehav Rev. 2017 Sep;80:729-742
pubmed: 28642070
Autism Res. 2019 Apr;12(4):645-657
pubmed: 30741482
Hum Brain Mapp. 2017 Nov;38(11):5740-5755
pubmed: 28792117
Acta Psychiatr Scand. 2018 Nov;138(5):379-400
pubmed: 29904907
Dialogues Clin Neurosci. 2018 Jun;20(2):133-140
pubmed: 30250390
Brain. 1999 Jul;122 ( Pt 7):1305-15
pubmed: 10388796
Mol Psychiatry. 2019 Oct;24(10):1435-1450
pubmed: 30617272
Nat Neurosci. 2015 Feb;18(2):302-9
pubmed: 25599222
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
Neuroimage. 2002 Oct;17(2):825-41
pubmed: 12377157
Schizophr Res. 2016 Aug;175(1-3):12-19
pubmed: 27083780
Neuropsychol Rehabil. 2016;26(3):464-79
pubmed: 26145159
Trends Cogn Sci. 2012 Sep;16(9):454-7
pubmed: 22835639
Lancet. 2018 Apr 28;391(10131):1683-1692
pubmed: 29726344
Neuroimage. 2009 Oct 15;48(1):63-72
pubmed: 19573611
Neuropsychology. 2015 May;29(3):445-53
pubmed: 25313979
Am J Psychiatry. 2003 Oct;160(10):1847-62
pubmed: 14514501
J Neurodev Disord. 2014;6(1):19
pubmed: 25057329
Autism. 2020 Jan;24(1):221-232
pubmed: 31215791
Nat Neurosci. 2015 Nov;18(11):1664-71
pubmed: 26457551
Mol Psychiatry. 2018 May;23(5):1198-1204
pubmed: 28439105
Brain Stimul. 2020 May - Jun;13(3):539-547
pubmed: 32289673
Nat Neurosci. 2013 Sep;16(9):1348-55
pubmed: 23892552
J Child Psychol Psychiatry. 2014 Apr;55(4):374-83
pubmed: 24256459
J Child Adolesc Psychopharmacol. 2017 Jun;27(5):413-421
pubmed: 28346865
Am J Psychiatry. 2019 Jul 1;176(7):521-530
pubmed: 30606045
Neuroimage. 2012 Feb 1;59(3):2142-54
pubmed: 22019881
Neuroimage Clin. 2014 Feb 25;4:444-53
pubmed: 25101235
Cereb Cortex. 2008 May;18(5):1201-9
pubmed: 17925295
Neuropsychol Rev. 2017 Mar;27(1):46-61
pubmed: 28102493
Annu Rev Public Health. 2017 Mar 20;38:81-102
pubmed: 28068486
Front Neuroinform. 2017 Feb 21;11:17
pubmed: 28270762
PLoS One. 2010 Jul 13;5(7):e11571
pubmed: 20644633

Auteurs

Colin Hawco (C)

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College St., Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Laagishan Yoganathan (L)

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College St., Toronto, ON, Canada; Department of Psychology, Neuroscience & Behaviour, McMaster University, Hamilton, ON, Canada.

Aristotle N Voineskos (AN)

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College St., Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Rachael Lyon (R)

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College St., Toronto, ON, Canada.

Thomas Tan (T)

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College St., Toronto, ON, Canada.

Zafiris J Daskalakis (ZJ)

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College St., Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Daniel M Blumberger (DM)

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College St., Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Paul E Croarkin (PE)

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.

Meng-Chuan Lai (MC)

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College St., Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, The Hospital for Sick Children, Toronto, ON, Canada; Margaret and Wallace McCain Centre for Child, Youth & Family Mental Health, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Peter Szatmari (P)

Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, The Hospital for Sick Children, Toronto, ON, Canada; Margaret and Wallace McCain Centre for Child, Youth & Family Mental Health, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Stephanie H Ameis (SH)

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College St., Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, The Hospital for Sick Children, Toronto, ON, Canada; Margaret and Wallace McCain Centre for Child, Youth & Family Mental Health, Centre for Addiction and Mental Health, Toronto, ON, Canada. Electronic address: stephanie.ameis@camh.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH